Treat-to-target HbA<sub>1c</sub> and lipid profile to prolong β-cell mass/function and optimize treatment goal attainment.

JJ, Gagliardino; J, Elgart; L, Forti; MS, Guaita; JM, Chantelot

doi:10.1002/dmrr.3166

Public

Treat-to-target HbA1c and lipid profile to prolong β-cell mass/function and optimize treatment goal attainment.

Shared by NobleBlocks on May 27, 2019 • 12:00 AM UTC

Authors:

Gagliardino JJ

Elgart J

Forti L

Abstract

Background To evaluate the relation between different serum lipid fractions and other known barriers to attain the HbA1c ≤ 7.0% (53 mmol/mol) target.Methods Data on 2719 patients with type 2 diabetes were collected from the five waves of the International Diabetes Mellitus Practice Study implemented...

Subject

β cell

Lipid Profiles

Ldl Cholesterol

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!